Mai F. Tolba
机构: Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University
每年引用次数
引用次数
引用: 1,587
H-指数: 21
I10-指数 : 33
出版物: 58
Potential targets of energy restriction mimetic agents in cancer cells
Hany A Omar , Mai F Tolba , Maha M Saber-Ayad
Future Oncology 10 ( 16) 2547 -2550
3
2014
The natural isoflavone Biochanin-A synergizes 5-fluorouracil anticancer activity in vitro and in vivo in Ehrlich solid-phase carcinoma model
Mohamed Mahmoud , Maha RA Abdollah , Mohamed E Elsesy , Dalal A Abou El Ella
Phytotherapy Research 36 ( 3) 1310 -1325
7
2022
Antioxidant and Hepatoprotective Activities of Flavonoids from Bauhinia hookeri
Eman Al-Sayed , Mai F Tolba , Maarit Karonen
Rec. Nat. Prod
8
2016
SARS-CoV-2 viral shedding and transmission dynamics: implications of WHO COVID-19 discharge guidelines
Kingsley Badu , Kolapo Oyebola , Julien ZB Zahouli , Adeniyi Francis Fagbamigbe
Frontiers in Medicine 8 648660 -648660
40
2021
Implications of WHO COVID-19 interim guideline 2020.5 on the comprehensive care for infected persons in Africa Before, during and after clinical management of cases
Adeniyi Francis Fagbamigbe , Mai F Tolba , Ebenezer F Amankwaa , Priscilla Kolibea Mante
Scientific African 15 e01083 -e01083
4
2022
Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
Mai F Tolba , Cesar A Santa-Maria , Adriana Albini , Emile R Chimusa
Frontiers in Oncology 11 752689 -752689
2
2021
The impact of NF-κB inhibition on the sensitivity of breast cancer cells to chemotherapy-induced apoptosis
Shifaa M Abdin , Mai F Tolba , Dana M Zaher , Hany A Omar
Cancer Research 80 ( 16_Supplement) 4107 -4107
2020
Constraining Multi‐Drug Resistance in Breast Cancer Cells by Energy Restriction
Hany A Omar , Dana M Zaher , Mai F Tolba , Taleb H Al‐Tel
The FASEB Journal 33 ( S1) 675.18 -675.18
2019
The impact of catechol estrogen metabolism on the proliferation rate and Docetaxel (DOC) resistance in hormone-responsive cancers
Mai F Tolba , Hany Omar , Ayman M Noreddin
Cancer Research 77 ( 13_Supplement) 4174 -4174
2017
Tackling liver cancer by a novel combination between OSU‐2S and sorafenib
Hany A Omar , Mai F Tolba , Jui‐Hsiang Hung , Taleb H Al‐Tel
The FASEB Journal 31 671.1 -671.1
2017
519 Caffeic Acid Phenethyl Ester Guards Against Benign Prostate Hypertrophy in Rats: Role of IGF-1R/Protein Kinase-B (Akt)/b-Catenin Signaling
Hany A Omar , Mai F Tolba
Insights into the therapeutic potential of histone deacetylase inhibitor/immunotherapy combination regimens in solid tumors
Nada K Sedky , Alyaa A Hamdan , Salma Emad , Aya L Allam
Clinical and Translational Oncology 24 ( 7) 1262 -1273
13
2022
The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson's disease in rats
Christine N Habib , Mohamed R Mohamed , Mariane G Tadros , Mai F Tolba
European Journal of Pharmacology 914 174573 -174573
19
2022
Rosuvastatin and low‐dose carvedilol combination protects against isoprenaline‐induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO‐1 signalling
Sarah A Baraka , Mai F Tolba , Doaa A Elsherbini , Reem N El‐Naga
Clinical and Experimental Pharmacology and Physiology 48 ( 10) 1358 -1370
11
2021
Insights into the therapeutic outcomes of trimetazidine/doxorubicin combination in Ehrlich solid-phase carcinoma mouse tumor model
Somaya M Abdeljalil , Sara A Wahdan , Hesham Elghazaly , Mai F Tolba
Life Sciences 328 121874 -121874
3
2023
Emerging talents in pharmacology of anti-cancer drugs 2022
Husain Yar Khan , Khuloud Bajbouj , Mai F Tolba
Frontiers in Pharmacology 14 1191321 -1191321
2023
Modeling neurotoxin-induced neuroinflammation with chemotherapy
Mai F Tolba , Nada K Sedky , Marwa A Ali , Maha RA Abdollah
Academic Press 403 -417
2023
CONCISE ARTICLE
Nermin S Abdou , Rabah AT Serya , Ahmed Esmat , Mai F Tolba
Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells.
Hany A. Omar , Hany A. Omar , Mai F. Tolba , Mai F. Tolba
Chemico-Biological Interactions 340 109450 -109450
2021
Abstract A23: Novel approach for targeting hepatocellular carcinoma cell survival: OSU-2S/Sorafenib combination
Hany A. Omar , Mai F. Tolba , Jui-Hsiang Hung , Taleb H. Al-Tel
Clinical Cancer Research 23
2017
Ashraf B. Abdel-Naim Dalal Abou El Ella Khaled Abouzid El-Serafi, Ahmed Taher Kolapo Oyebola Kingsley Badu Priscilla Kolibea Mante Dziedzom K. de Souza Damaris Matoke-Muhia lydia mosi Adeniyi Francis Fagbamigbe Natisha Dukhi Augustina Angelina Sylverken Ebenezer Forkuo Amankwaa Esther Tharwat Menz Yonan Jui Hsiang Hung Shifaa Abdin Mariane George Tadros